Proton magnetic resonance spectroscopy of the medial prefrontal cortex in patients with deficit schizophrenia: Preliminary report

American Journal of Psychiatry

Volumn 157, Issue 4, 2000, Pages 641-643

  Delamillieure, Pascal ^b   Fernandez, Jésus ^b   Constans, Jean Marc ^b   Brazo, Perrine ^b   Benali, Karim ^b   Abadie, Pascale ^b   Vasse, Thierry ^b   Thibaut, Florence ^b   Courthéoux, Patrick ^b   Petit, Michel ^b   Dollfus, Sonia ^a  

^a CAEN UNIVERSITY HOSPITAL   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE PHOSPHATE; N ACETYLASPARTIC ACID;

ADULT; ARTICLE; BRAIN METABOLISM; CELL LOSS; CELL VIABILITY; CLINICAL ARTICLE; COGNITIVE DEFECT; FEMALE; GLIOSIS; HUMAN; MALE; NEGATIVE SYNDROME; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RECEPTOR DENSITY; SCHIZOPHRENIA; WHITE MATTER;

ASPARTIC ACID; CELL COUNT; CREATINE; FUNCTIONAL LATERALITY; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; NEURONS; PHOSPHOCREATINE; PREFRONTAL CORTEX; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 0034037340     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.157.4.641     Document Type: Article

References (11)

1. Bertolino A, Nawroz S, Mattay VS, Barnett AS, Duyn JH, Moonen CT, Frank JA, Tedeschi G, Weinberger DR: Regionally specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging. Am J Psychiatry 1996; 153:1554-1563
2. Buckley PF, Moore C, Long H, Larkin C, Thompson P, Mulvany F, Redmond O, Stack JP, Ennis JT, Waddington JL: 1H-magnetic resonance spectroscopy of the left temporal and frontal lobes in schizophrenia: clinical, neurodevelopmental, and cognitive correlates. Biol Psychiatry 1994; 36:792-800
3. Williamson PC, Bartha R, Drost DJ, Malla A, Carr T, Canaran G, Densmore M, Neufeld RW: Medial prefrontal 1H MRS and MRI findings in never-treated schizophrenics and healthy controls (abstract). Schizophr Res 1998; 29:101
4. Carpenter WT Jr, Heinrichs DW, Wagman AM: Deficit and nondeficit forms of schizophrenia: the concept. Am J Psychiatry 1988; 145:578-583
5. Kirkpatrick B, Buchanan RW, McKenney PD, Alphs LD, Carpenter WT Jr: The Schedule for the Deficit Syndrome: an instrument for research in schizophrenia. Psychiatry Res 1989; 30:119-123
6. Robins LN, Heizer JE, Croughan J, Ratcliff KS: National Institute of Metal Health Diagnostic Interview Schedule: its history, characteristics and validity. Arch Gen Psychiatry 1981; 38: 381-389
7. Tamminga CA, Thaker GK, Buchanan R, Kirkpatrick B, Alphs LD, Chase TN, Carpenter WT: Limbic system abnormalities identified in schizophrenia using positron emission tomography with fluorodeoxyglucose and neocortical alterations with deficit syndrome. Arch Gen Psychiatry 1992; 49:522-530
8. Shioiri T, Kalo T, Inubushi T, Murashita J, Takahashi S: Correlations of phosphomonoesters measured by phosphorus-31 magnetic resonance spectroscopy in the frontal lobes and negative symptoms in schizophrenia. Psychiatry Res 1994; 55:223-235
9. Bertolino A, Callicott JH, Elman I, Mattay VS, Tedeschi G, Frank JA, Breier A, Weinberger DR: Regionally specific neuronal pathology in untreated patients with schizophrenia: a proton magnetic resonance spectroscopic imaging study. Biol Psychiatry 1998; 43:641-648
10. Lim KO, Adalsteinsson E, Spielman D, Sullivan EV, Rosenbloom MJ, Pfefferbaum A: Proton magnetic resonance spectroscopic imaging of cortical gray and white matter in schizophrenia. Arch Gen Psychiatry 1998; 55:346-352
11. Buchanan RW, Breier A, Kirkpatrick B, Elkashef A, Munson RC, Gellad F, Carpenter WT Jr: Structural abnormalities in deficit and nondeficit schizophrenia. Am J Psychiatry 1993; 150:59-65